The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Acetaminophen (APAP) hepatotoxicity—Isn’t it time for APAP to go away?
Open accessAbstract
Summary Acetaminophen (APAP) is the most commonly used drug for the treatment of pain and fever around the world. At the same time, APAP is capable of causing dose-related hepatocellular necrosis, responsible for nearly 500 deaths annually in the U.S. alone, as well as 100,000 calls to US Poison Control Centers, 50,000 emergency room visits and 10,000 hospitalizations per year. As an over-the-counter and prescription product (with opioids), APAP toxicity dwarfs all other prescription drugs as a cause for acute liver failure in the United States and Europe, but is not regulated in any significant way. This review will highlight the ongoing controversy as to the proper role for this ubiquitous pain reliever: its history, pathogenesis, clinical challenges in recognition and management, and current regulatory status and propose a new solution to a 50-year-old problem.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ostapowicz, G., Fontana, R. J., Schiødt, F. V., Larson, A., Davern, T. J., Han, S. H. B., McCashland, T. M., Shakil, A. O., Hay, J. E., Hynan, L., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-12-200212170-00007 · Cited by 2,227
Self-citationIncreases in drug and opioid-involved overdose deaths – United States, 2010-2015
Rudd, R. A., Seth, P., David, F., & Scholl, L. (2016) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm655051e1 · Cited by 2,194
Larson, A. M., Polson, J., Fontana, R. J., Davern, T. J., Lalani, E., Hynan, L. S., Reisch, J. S., Schiødt, F. V., Ostapowicz, G., Shakil, A. O., et al. (2005) · Hepatology · doi:10.1002/hep.20948 · Cited by 1,926
Self-citationBernal, W., Auzinger, G., Dhawan, A., & Wendon, J. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60274-7 · Cited by 996
Mowry, J. B., Spyker, D. A., Cantilena, L. R., McMillan, N., & Ford, M. (2014) · Clinical Toxicology · doi:10.3109/15563650.2014.987397 · Cited by 849
Lee, W. M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312163292508 · Cited by 546
Self-citationMitchell, J. R., Thorgeirsson, S. S., Potter, W. Z., Jollow, D. J., & Keiser, H. (1974) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1974164676 · Cited by 532
Kon, K., Kim, J.-S., Jaeschke, H., & Lemasters, J. J. (2004) · Hepatology · doi:10.1002/hep.20437 · Cited by 494
Zimmerman, H. J., & Maddrey, W. C. (1995) · Hepatology · doi:10.1002/hep.1840220312 · Cited by 460
Acetaminophen Hepatotoxicity in Alcoholics: A Therapeutic Misadventure
SEEFF, L. B., CUCCHERINI, B. A., ZIMMERMAN, H. J., ADLER, E., & BENJAMIN, S. B. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-104-3-399 · Cited by 424
Cited by
Yamada, N., Karasawa, T., Kimura, H., Watanabe, S., Komada, T., Kamata, R., Sampilvanjil, A., Ito, J., Nakagawa, K., Kuwata, H., et al. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2334-2 · Cited by 338
Ramachandran, A., & Jaeschke, H. (2019) · Seminars in Liver Disease · doi:10.1055/s-0039-1679919 · Cited by 326
Cheng, D., Peng, J., Lv, Y., Su, D., Liu, D., Chen, M., Yuan, L., & Zhang, X. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b01374 · Cited by 308
Paracetamol: A Review of Guideline Recommendations
Freo, U., Ruocco, C., Valerio, A., Scagnol, I., & Nisoli, E. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10153420 · Cited by 208
“Furthermore, drug-induced liver injury is a diagnosis of exclusion that has been ascribed almost only to paracetamol [143].”
BackgroundParacetamol – An old drug with new mechanisms of action
Przybyła, G. W., Szychowski, K. A., & Gmiński, J. (2021) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13392 · Cited by 190
Hu, S., Liu, S., Bian, Y., Poddar, M., Singh, S., Cao, C., McGaughey, J., Bell, A., Blazer, L. L., Adams, J. J., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100754 · Cited by 118
Management of Acute Liver Failure: Update 2022
Tujios, S., Stravitz, R. T., & Lee, W. M. (2022) · Seminars in Liver Disease · doi:10.1055/s-0042-1755274 · Cited by 117
Self-citationFoster, A. J., Chouhan, B., Regan, S. L., Rollison, H., Amberntsson, S., Andersson, L. C., Srivastava, A., Darnell, M., Cairns, J., Lazic, S. E., et al. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02427-4 · Cited by 117
Luo, D.-D., Chen, J.-F., Liu, J.-J., Xie, J.-H., Zhang, Z.-B., Gu, J.-Y., Zhuo, J.-Y., Huang, S., Su, Z.-R., & Sun, Z.-H. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.11.012 · Cited by 77
Macrophages as a Cell-Based Therapy for Liver Disease
Starkey Lewis, P. J., Moroni, F., & Forbes, S. J. (2019) · Seminars in Liver Disease · doi:10.1055/s-0039-1688502 · Cited by 36
Orandi, B. J., McLeod, M. C., MacLennan, P. A., Lee, W. M., Fontana, R. J., Karvellas, C. J., McGuire, B. M., Lewis, C. E., Terrault, N. M., Locke, J. E., et al. (2023) · JAMA · doi:10.1001/jama.2023.1080 · Cited by 30
Self-citationTeschke, R., Eickhoff, A., Brown, A. C., Neuman, M. G., & Schulze, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010212 · Cited by 30
Wang, C., Deng, Y., Li, P., Zheng, S., Chen, G., Zhou, G., Xu, J., Chen, Y., Wang, Z., Jin, X., et al. (2022) · Hepatology · doi:10.1002/hep.32283 · Cited by 28
Niu, M., Luo, Z., Gong, S., Win, S., Kaplowitz, N., Jiang, Y., & Chen, P. (2020) · The American Journal of Pathology · doi:10.1016/j.ajpath.2019.09.009 · Cited by 26
Old problem, new solutions: biomarker discovery for acetaminophen liver toxicity
Gloor, Y., Schvartz, D., & F.Samer, C. (2019) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2019.1642323 · Cited by 18
You, K., Wang, Y., Chen, X., Yang, Z., Chen, Y., Tan, S., Tao, J., Getachew, A., Pan, T., Xu, Y., et al. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.11.079 · Cited by 9
Emerging Roles of High-mobility Group Box-1 in Liver Disease
Wang, L., Dong, Z., Zhang, Y., & Peng, L. (2024) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2024.00317 · Cited by 8
Metadata
- Authors
- Lee, W. M.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2017-12
- Volume
- 67
- Issue
- 6
- Pages
- 1324-1331
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2737518257
- Cited by
- 442
- References
- 43
- FWCI
- 28.56
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.